Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1983 Aug;198(2):200–206. doi: 10.1097/00000658-198308000-00015

Judging prognosis in malignant melanoma of the skin. A problem of inference over small data sets.

M S Blois, R W Sagebiel, M S Tuttle, T M Caldwell, H W Taylor
PMCID: PMC1353080  PMID: 6870378

Abstract

Data was generated for 828 clinical stage 1 melanoma patients, divided into groups according to sex, tumor location, and tumor level for each of the 56 groups. Summary data, including the number of patients, number of patients dying as a result of melanoma, range of tumor thickness, mean and median tumor thickness, and mean length of follow-up of the surviving patients, are shown. Patients with melanoma of the palms and soles, subungual melanomas, and mucosal melanomas were excluded. A physician with a new melanoma patient could select the appropriate group for his or her patient, matched with respect to sex, location, and level, and then make a judgment regarding the prognosis, based on the survival experience of the group. In a few groups, the small numbers of patients provides only a rough impression of survival, but with many groups, a fair estimate can be made. The effectiveness of elective lymph node dissection was examined by creating 111 pairs of patients, matched by sex, level, location, and tumor thickness (to within +/- 12%), in which one member of the pair had an elective node dissection (ELND) and the other did not. There was no statistically significant difference between the survival of the two groups.

Full text

PDF
200

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ariel I. M. Malignant melanoma of the lower extremity: evaluation of 453 patients. J Surg Oncol. 1980;15(2):147–169. doi: 10.1002/jso.2930150207. [DOI] [PubMed] [Google Scholar]
  2. Bagley F. H., Cady B., Lee A., Legg M. A. Changes in clinical presentation and management of malignant melanoma. Cancer. 1981 May 1;47(9):2126–2134. doi: 10.1002/1097-0142(19810501)47:9<2126::aid-cncr2820470904>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  3. Balch C. M., Murad T. M., Soong S. J., Ingalls A. L., Halpern N. B., Maddox W. A. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg. 1978 Dec;188(6):732–742. doi: 10.1097/00000658-197812000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Balch C. M., Murad T. M., Soong S. J., Ingalls A. L., Richards P. C., Maddox W. A. Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer. 1979 Mar;43(3):883–888. doi: 10.1002/1097-0142(197903)43:3<883::aid-cncr2820430316>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  5. Breslow A., Cascinelli N., van der Esch E. P., Morabito A. Stage I melanoma of the limbs: assessment of prognosis by levels of invasion and maximum thickness. Tumori. 1978 Jun 30;64(3):273–284. doi: 10.1177/030089167806400305. [DOI] [PubMed] [Google Scholar]
  6. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970 Nov;172(5):902–908. doi: 10.1097/00000658-197011000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Clark W. H., Jr, From L., Bernardino E. A., Mihm M. C. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969 Mar;29(3):705–727. [PubMed] [Google Scholar]
  8. Cohen M. H., Ketcham A. S., Felix E. L., Li S. H., Tomaszewski M. M., Costa J., Rabson A. S., Simon R. M., Rosenberg S. A. Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg. 1977 Nov;186(5):635–642. doi: 10.1097/00000658-197711000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DASGUPTA T., MCNEER G. THE INCIDENCE OF METASTASIS TO ACCESSIBLE LYMPH NODES FROM MELANOMA OF THE TRUNK AND EXTREMITIES--ITS THERAPEUTIC SIGNIFICANCE. Cancer. 1964 Jul;17:897–911. doi: 10.1002/1097-0142(196407)17:7<897::aid-cncr2820170710>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  10. Day C. L., Jr, Mihm M. C., Jr, Sober A. J., Fitzpatrick T. B., Malt R. A. Narrower margins for clinical stage I malignant melanoma. N Engl J Med. 1982 Feb 25;306(8):479–482. doi: 10.1056/NEJM198202253060810. [DOI] [PubMed] [Google Scholar]
  11. Day C. L., Jr, Mihm M. C., Jr, Sober A. J., Harris M. N., Kopf A. W., Fitzpatrick T. B., Lew R. A., Harrist T. J., Golomb F. M., Postel A. Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions. Ann Surg. 1982 Jan;195(1):30–34. doi: 10.1097/00000658-198201001-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Day C. L., Jr, Sober A. J., Kopf A. W., Lew R. A., Mihm M. C., Jr, Golomb F. M., Hennessey P., Harris M. N., Gumport S. L., Raker J. W. A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease. Surgery. 1981 May;89(5):599–603. [PubMed] [Google Scholar]
  13. Day C. L., Jr, Sober A. J., Kopf A. W., Lew R. A., Mihm M. C., Jr, Golomb F. M., Postel A., Hennessey P., Harris M. N., Gumport S. L. A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease. Am J Surg. 1981 Aug;142(2):247–251. doi: 10.1016/0002-9610(81)90286-5. [DOI] [PubMed] [Google Scholar]
  14. Day C. L., Jr, Sober A. J., Kopf A. W., Lew R. A., Mihm M. C., Jr, Hennessey P., Golomb F. M., Harris M. N., Gumport S. L., Raker J. W. A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease. Ann Surg. 1981 Apr;193(4):436–440. doi: 10.1097/00000658-198104000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Elias E. G., Didolkar M. S., Goel I. P., Formeister J. F., Valenzuela L. A., Pickren J. L., Moore R. H. A clinicopathologic study of prognostic factors in cutaneous malignant melanoma. Surg Gynecol Obstet. 1977 Mar;144(3):327–334. [PubMed] [Google Scholar]
  16. Goldsmith H. S., Shah J. P., Kim D. H. Prognostic significance of lymph node dissection in the treatment of malignant melanoma. Cancer. 1970 Sep;26(3):606–609. doi: 10.1002/1097-0142(197009)26:3<606::aid-cncr2820260317>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  17. Heite H. J. Klinik und Prognose des malignen Melanoms. Haematol Blood Transfus. 1978;21:233–247. [PubMed] [Google Scholar]
  18. Kopf A. W., Rigel D., Bart R. S., Mintzis M. M., Hennessey P., Harris M. N., Ragaz A., Trau H., Friedman R. J., Esrig B. Factors related to thickness of melanoma. Multifactorial analysis off variables correlated with thickness of superficial spreading malignant melanoma in man. J Dermatol Surg Oncol. 1981 Aug;7(8):645–650. doi: 10.1111/j.1524-4725.1981.tb00712.x. [DOI] [PubMed] [Google Scholar]
  19. MEHNERT J. H., HEARD J. L. STAGING OF MALIGNANT MELANOMAS BY DEPTH OF INVASION; A PROPOSED INDEX TO PROGNOSIS. Am J Surg. 1965 Aug;110:168–176. doi: 10.1016/0002-9610(65)90008-5. [DOI] [PubMed] [Google Scholar]
  20. McGovern V. J. The classification of melanoma and its relationship with prognosis. Pathology. 1970 Apr;2(2):85–98. doi: 10.3109/00313027009077330. [DOI] [PubMed] [Google Scholar]
  21. Rampen F. Changing concepts in melanoma management. Br J Dermatol. 1981 Mar;104(3):341–348. doi: 10.1111/j.1365-2133.1981.tb00960.x. [DOI] [PubMed] [Google Scholar]
  22. Shaw H. M., McGovern V. J., Milton G. W., Farago G. A., McCarthy W. H. Malignant melanoma: influence of site of lesion and age of patient in the female superiority in survival. Cancer. 1980 Dec 15;46(12):2731–2735. doi: 10.1002/1097-0142(19801215)46:12<2731::aid-cncr2820461232>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  23. Veronesi U., Adamus J., Bandiera D. C., Brennhovd I. O., Caceres E., Cascinelli N., Claudio F., Ikonopisov R. L., Javorskj V. V., Kirov S. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med. 1977 Sep 22;297(12):627–630. doi: 10.1056/NEJM197709222971202. [DOI] [PubMed] [Google Scholar]
  24. Wanebo H. J., Woodruff J., Fortner J. G. Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer. 1975 Mar;35(3):666–676. doi: 10.1002/1097-0142(197503)35:3<666::aid-cncr2820350320>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES